Cisplatin-based Electrochemotherapy Significantly Downregulates Key Heat Shock Proteins in MDA-MB-231-Human...

Area of Science:

• Molecular Biology
• Cellular Stress Response
• Cancer Research

Background:

• Heat shock proteins (HSPs) are crucial molecular chaperones involved in cellular protection against diverse environmental and pathological stresses.
• HSPs play a role in maintaining cellular homeostasis and are implicated in various diseases, including cancer.
• Triple-negative breast cancer (TNBC) remains a challenging malignancy with limited targeted treatment options.

Purpose of the Study:

• To investigate the role of heat shock proteins (HSPs) in triple-negative breast cancer (TNBC) cells under combined stress conditions.
• To identify potential therapeutic targets within the HSP family for TNBC treatment.

Main Methods:

• Utilized label-free, high-throughput quantitative LC-MS/MS-based proteomics.
• Analyzed MDA-MB-231 human TNBC cells treated with electrical pulses (EP) and cisplatin (CsP).
• Compared proteomic profiles of cells treated with EP + CsP versus CsP alone.

Main Results:

• Identified significant downregulation of several HSPs, including HSP90AA1, in TNBC cells treated with EP + CsP compared to CsP alone.
• Observed that the downregulation of HSPs correlates with increased apoptotic cell death.
• Suggests a potential mechanism for enhanced cancer cell killing through combined EP and CsP treatment.

Conclusions:

• Heat shock proteins (HSPs) represent a promising, yet untapped, resource for developing novel therapeutic strategies against triple-negative breast cancer.
• Downregulation of specific HSPs may serve as a predictive biomarker for treatment response.
• Targeting HSPs could lead to new biomarkers and inhibitors for effective TNBC therapies.